Zealand Pharma A/S (OTCPK:ZLDPF)
$ 90.7 2.025 (2.28%) Market Cap: 5.64 Bil Enterprise Value: 5.21 Bil PE Ratio: 0 PB Ratio: 13.48 GF Score: 52/100

Zealand Pharma A/S at Needham Healthcare Conference (Virtual) Transcript

Apr 19, 2023 / 12:00PM GMT
Release Date Price: $31.11
Joey Stringer
Needham & Company, LLC - Analyst

Good morning, everyone. Thank you for joining the 22nd Annual Needham Healthcare Conference. My name is Joey Stringer, and I'm one of the biotech analysts at Needham and Company. It's my pleasure to introduce our next presenting company, Zealand Pharma.

Joining us today from Zealand is CEO Adam Steensberg. Following the presentation, we'll have a brief Q&A session. (Conference Instructions)

So with that, we'll get started. I'll turn it over to Adam for the presentation.

Adam Steensberg;S;CEO
Zealand Pharma A

/-

Thanks, Joey, and thanks for participating in this virtual call, all of you guys. So it's really a pleasure for me today to present Zealand Pharma. So we are a Danish-based company who have been working with peptide drug discovery and development for 25 years now. So our headquarters is in Denmark, but we also have employees in the US, so we consider ourselves an international company.

I will be making forward-looking statements today, as

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot